Kalyani Steels Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 28, 2025, 8:50 pm

Quick Insight

Kalyani Steels Ltd, with a current share price of 835 and a market capitalization of 3,645 Cr., presents an intriguing investment opportunity within the steel-rolling industry. The company's P/E ratio of 13.9 indicates a reasonable valuation, while its robust ROE of 14.0% and ROCE of 15.6% reflect efficient capital utilization. With an operating profit margin of 19% and a healthy net profit of 253 Cr., Kalyani Steels exhibits solid operational performance. Furthermore, the company's comfortable ICR of 16.19x and a moderate P/BV ratio of 2.22x suggest a strong financial position. Investors may find value in exploring Kalyani Steels for potential long-term growth prospects in the steel sector.

Competitors of Kalyani Steels Ltd

All Competitor Stocks of Kalyani Steels Ltd

Quarterly Result

Last Updated: August 1, 2025, 6:35 pm

Below is a detailed analysis of the quarterly data for Kalyani Steels Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 443.00 Cr.. The value appears to be declining and may need further review. It has decreased from 544.00 Cr. (Mar 2025) to 443.00 Cr., marking a decrease of 101.00 Cr..
• For Expenses, as of Jun 2025, the value is 357.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 430.00 Cr. (Mar 2025) to 357.00 Cr., marking a decrease of 73.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 85.00 Cr.. The value appears to be declining and may need further review. It has decreased from 114.00 Cr. (Mar 2025) to 85.00 Cr., marking a decrease of 29.00 Cr..
• For OPM %, as of Jun 2025, the value is 19.00%. The value appears to be declining and may need further review. It has decreased from 21.00% (Mar 2025) to 19.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 15.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.00 Cr. (Mar 2025) to 15.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 82.00 Cr.. The value appears to be declining and may need further review. It has decreased from 107.00 Cr. (Mar 2025) to 82.00 Cr., marking a decrease of 25.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00%.
• For Net Profit, as of Jun 2025, the value is 61.00 Cr.. The value appears to be declining and may need further review. It has decreased from 79.00 Cr. (Mar 2025) to 61.00 Cr., marking a decrease of 18.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 13.97. The value appears to be declining and may need further review. It has decreased from 18.16 (Mar 2025) to 13.97, marking a decrease of 4.19.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 6:11 am

Balance Sheet

Last Updated: May 13, 2025, 3:15 pm

Below is a detailed analysis of the balance sheet data for Kalyani Steels Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 22.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 22.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,883.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,670.00 Cr. (Mar 2024) to 1,883.00 Cr., marking an increase of 213.00 Cr..
• For Borrowings, as of Mar 2025, the value is 438.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 596.00 Cr. (Mar 2024) to 438.00 Cr., marking a decrease of 158.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 403.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 297.00 Cr. (Mar 2024) to 403.00 Cr., marking an increase of 106.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,745.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,584.00 Cr. (Mar 2024) to 2,745.00 Cr., marking an increase of 161.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 678.00 Cr.. The value appears to be declining and may need further review. It has decreased from 734.00 Cr. (Mar 2024) to 678.00 Cr., marking a decrease of 56.00 Cr..
• For CWIP, as of Mar 2025, the value is 429.00 Cr.. The value appears strong and on an upward trend. It has increased from 381.00 Cr. (Mar 2024) to 429.00 Cr., marking an increase of 48.00 Cr..
• For Investments, as of Mar 2025, the value is 150.00 Cr.. The value appears strong and on an upward trend. It has increased from 145.00 Cr. (Mar 2024) to 150.00 Cr., marking an increase of 5.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,487.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,324.00 Cr. (Mar 2024) to 1,487.00 Cr., marking an increase of 163.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,745.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,584.00 Cr. (Mar 2024) to 2,745.00 Cr., marking an increase of 161.00 Cr..

Notably, the Reserves (1,883.00 Cr.) exceed the Borrowings (438.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Kalyani Steels Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 56.99. This value is within the healthy range. It has increased from 55.93 (Mar 22) to 56.99, marking an increase of 1.06.
• For Diluted EPS (Rs.), as of Mar 24, the value is 56.99. This value is within the healthy range. It has increased from 55.93 (Mar 22) to 56.99, marking an increase of 1.06.
• For Cash EPS (Rs.), as of Mar 24, the value is 70.79. This value is within the healthy range. It has increased from 67.14 (Mar 22) to 70.79, marking an increase of 3.65.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 384.18. It has increased from 312.72 (Mar 22) to 384.18, marking an increase of 71.46.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 384.18. It has increased from 312.72 (Mar 22) to 384.18, marking an increase of 71.46.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 448.11. It has increased from 390.15 (Mar 22) to 448.11, marking an increase of 57.96.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 95.55. This value is within the healthy range. It has increased from 89.19 (Mar 22) to 95.55, marking an increase of 6.36.
• For PBIT / Share (Rs.), as of Mar 24, the value is 81.66. This value is within the healthy range. It has increased from 78.70 (Mar 22) to 81.66, marking an increase of 2.96.
• For PBT / Share (Rs.), as of Mar 24, the value is 76.18. This value is within the healthy range. It has increased from 75.61 (Mar 22) to 76.18, marking an increase of 0.57.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 56.89. This value is within the healthy range. It has increased from 56.65 (Mar 22) to 56.89, marking an increase of 0.24.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 56.89. This value is within the healthy range. It has increased from 55.83 (Mar 22) to 56.89, marking an increase of 1.06.
• For PBDIT Margin (%), as of Mar 24, the value is 21.32. This value is within the healthy range. It has decreased from 22.86 (Mar 22) to 21.32, marking a decrease of 1.54.
• For PBIT Margin (%), as of Mar 24, the value is 18.22. This value is within the healthy range. It has decreased from 20.17 (Mar 22) to 18.22, marking a decrease of 1.95.
• For PBT Margin (%), as of Mar 24, the value is 16.99. This value is within the healthy range. It has decreased from 19.38 (Mar 22) to 16.99, marking a decrease of 2.39.
• For Net Profit Margin (%), as of Mar 24, the value is 12.69. This value exceeds the healthy maximum of 10. It has decreased from 14.52 (Mar 22) to 12.69, marking a decrease of 1.83.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 12.69. This value is within the healthy range. It has decreased from 14.31 (Mar 22) to 12.69, marking a decrease of 1.62.
• For Return on Networth / Equity (%), as of Mar 24, the value is 14.80. This value is below the healthy minimum of 15. It has decreased from 17.85 (Mar 22) to 14.80, marking a decrease of 3.05.
• For Return on Capital Employeed (%), as of Mar 24, the value is 19.92. This value is within the healthy range. It has decreased from 21.64 (Mar 22) to 19.92, marking a decrease of 1.72.
• For Return On Assets (%), as of Mar 24, the value is 9.66. This value is within the healthy range. It has decreased from 10.81 (Mar 22) to 9.66, marking a decrease of 1.15.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.04. This value is below the healthy minimum of 0.2. It has decreased from 0.13 (Mar 22) to 0.04, marking a decrease of 0.09.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.35. This value is within the healthy range. It has increased from 0.24 (Mar 22) to 0.35, marking an increase of 0.11.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.00. It has decreased from 0.87 (Mar 22) to 0.00, marking a decrease of 0.87.
• For Current Ratio (X), as of Mar 24, the value is 1.76. This value is within the healthy range. It has decreased from 2.33 (Mar 22) to 1.76, marking a decrease of 0.57.
• For Quick Ratio (X), as of Mar 24, the value is 1.39. This value is within the healthy range. It has decreased from 2.01 (Mar 22) to 1.39, marking a decrease of 0.62.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 5.76 (Mar 22) to 0.00, marking a decrease of 5.76.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 17.54. This value is below the healthy minimum of 20. It has increased from 13.41 (Mar 22) to 17.54, marking an increase of 4.13.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 14.10. This value is below the healthy minimum of 20. It has increased from 11.28 (Mar 22) to 14.10, marking an increase of 2.82.
• For Earning Retention Ratio (%), as of Mar 24, the value is 82.46. This value exceeds the healthy maximum of 70. It has decreased from 86.59 (Mar 22) to 82.46, marking a decrease of 4.13.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 85.90. This value exceeds the healthy maximum of 70. It has decreased from 88.72 (Mar 22) to 85.90, marking a decrease of 2.82.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 16.19. This value is within the healthy range. It has decreased from 28.90 (Mar 22) to 16.19, marking a decrease of 12.71.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 10.57. This value is within the healthy range. It has decreased from 19.36 (Mar 22) to 10.57, marking a decrease of 8.79.
• For Enterprise Value (Cr.), as of Mar 24, the value is 3,779.81. It has increased from 660.30 (Mar 22) to 3,779.81, marking an increase of 3,119.51.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.93. This value is within the healthy range. It has increased from 0.38 (Mar 22) to 1.93, marking an increase of 1.55.
• For EV / EBITDA (X), as of Mar 24, the value is 9.05. This value is within the healthy range. It has increased from 1.69 (Mar 22) to 9.05, marking an increase of 7.36.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.91. This value is within the healthy range. It has increased from 0.75 (Mar 22) to 1.91, marking an increase of 1.16.
• For Retention Ratios (%), as of Mar 24, the value is 82.45. This value exceeds the healthy maximum of 70. It has decreased from 86.58 (Mar 22) to 82.45, marking a decrease of 4.13.
• For Price / BV (X), as of Mar 24, the value is 2.22. This value is within the healthy range. It has increased from 0.94 (Mar 22) to 2.22, marking an increase of 1.28.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.91. This value is within the healthy range. It has increased from 0.75 (Mar 22) to 1.91, marking an increase of 1.16.
• For EarningsYield, as of Mar 24, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.18 (Mar 22) to 0.06, marking a decrease of 0.12.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness